GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Price-to-Owner-Earnings

Medipost Co (XKRX:078160) Price-to-Owner-Earnings : 1,454.73 (As of Apr. 30, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Price-to-Owner-Earnings?

As of today (2024-04-30), Medipost Co's share price is ₩7070.00. Medipost Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was ₩4.86. It's Price-to-Owner-Earnings for today is 1,454.73.


The historical rank and industry rank for Medipost Co's Price-to-Owner-Earnings or its related term are showing as below:

XKRX:078160' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.7   Med: 73.23   Max: 4117
Current: 1443.87

During the past 13 years, the highest Price-to-Owner-Earnings of Medipost Co was 4117.00. The lowest was 9.70. And the median was 73.23.


XKRX:078160's Price-to-Owner-Earnings is ranked worse than
98.22% of 169 companies
in the Biotechnology industry
Industry Median: 32.37 vs XKRX:078160: 1443.87

As of today (2024-04-30), Medipost Co's share price is ₩7070.00. Medipost Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩50.33. Therefore, Medipost Co's PE Ratio for today is 140.47.

As of today (2024-04-30), Medipost Co's share price is ₩7070.00. Medipost Co's EPS without NRI for the trailing twelve months (TTM) ended in was ₩-450.17. Therefore, Medipost Co's PE Ratio without NRI for today is At Loss.

During the past 13 years, Medipost Co's highest PE Ratio without NRI was 1454.16. The lowest was 0.00. And the median was 270.72.


Medipost Co Price-to-Owner-Earnings Historical Data

The historical data trend for Medipost Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Price-to-Owner-Earnings Chart

Medipost Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 67.49 1,680.74

Medipost Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.49 45.00 16.31 - 1,680.74

Competitive Comparison of Medipost Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Medipost Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipost Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medipost Co's Price-to-Owner-Earnings falls into.



Medipost Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medipost Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=7070.00/4.86
=1,454.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipost Co  (XKRX:078160) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medipost Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medipost Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipost Co (XKRX:078160) Business Description

Traded in Other Exchanges
N/A
Address
21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines